NCT06405685 2024-05-08
Nimotuzumab Plus AG in Pancreatic Cancer With Liver Metastasis
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown
Clinical Trials
21 trialsNCT03708822 2024-01-18
Study of Docetaxel and Cisplatin Combined With Nimotuzumab As First-Line Treatment in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 2 Unknown
NCT03620032 2023-12-06
DIPG
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2 Unknown
NCT05606263 2023-05-26
GCR-05
Xi'an Jiaotong University
Phase 2 Unknown
NCT03574402 2022-12-06
TRUMP
Guangdong Association of Clinical Trials
Phase 2 Unknown
NCT04367909 2021-11-08
A Study of TC(Docetaxel and Carboplatin) Regimen With or Without Nimotuzumab in Recurrent Metastatic Oral Squamous Cell Carcinoma
China Three Gorges University, Yichang, China
Phase 2 Unknown
NCT05024019 2021-08-27
Nimotuzumab Combined With Radiotherapy in High-risk Patients With HNSCC Not Suitable for Cisplatin After Surgery
Eye & ENT Hospital of Fudan University
Phase 2 Unknown
NCT03766178 2021-07-07
Study of Anti-PD-1 Antibody SHR-1210 Plus Nimotuzumab in the Treatment of Advanced Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University
Phase 2 Unknown
NCT04882462 2021-05-12
Carpp-1
The First Affiliated Hospital of Soochow University
Phase 2 Unknown
NCT04833205 2021-04-20
Clinical Efficacy and Safety of EGFR-TKI Combined With Nimotuzumab in the Treatment of Leptomeningeal Metastases From Lung Cancer
Hebei Medical University
Phase 2 Unknown
NCT03915132 2021-01-29
Nimotuzumab Combined With VMAT in Elderly Patients With Nasopharyngeal Carcinoma
ChineseAMS
Phase 2 Unknown
NCT02858206 2019-07-26
Simultaneous Integrated Boost Radiotherapy and Concurrent Nimotuzumab or Chemotherapy for Esophageal Carcinoma
ChineseAMS
Phase 2 Unknown
NCT03557112 2018-11-02
By Comparing TPF Induction Chemotherapy Combined With Nimotuzumab Concurrent Radiotherapy and Cisplatin Concurrent Radio-chemotherapy for Locally Advanced NPC
Guiyang Medical University
Phase 2 Unknown
NCT03666221 2018-09-11
Nimotuzumab for Recurrent Nasopharyngeal Carcinoma
Fujian Cancer Hospital
Phase 2 Unknown
NCT03469531 2018-08-13
Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer
Zhujiang Hospital
Phase 2 Unknown
NCT03400592 2018-01-17
NIEGA
Peking University
Phase 2 Unknown
NCT02705612 2016-03-10
Phase II Clinical Trial of Concurrent Chemoradiotherapy Combined Nimotuzumab for Stage IIB-IVA Cervical Cancer
Air Force Military Medical University, China
Phase 2 Unknown
NCT01232374 2015-08-20
Nimotuzumab in Combination With Chemoradiation for Local Advanced Esophageal Squamous Cell Carcinoma
Biotech Pharmaceutical Co., Ltd.
Phase 2 Unknown
NCT01516996 2012-03-20
Safety and Efficacy Study of Nimotuzumab Plus Neoadjuvant and Concurrent Chemoradiotherapy to Treat Oropharynx and Hypopharynx Cancer
The Second People's Hospital of Sichuan
Phase 2 Unknown
NCT01336049 2011-04-15
Nimotuzumab Plus Paclitaxel and Cisplatin as 1st Line Treatment for Esophageal Squamous Cell Cancer
Peking University
Phase 2 Unknown
NCT00972465 2009-09-07
Study of Nimotuzumab to Treat Colorectal Cancer
Peking University
Phase 2 Unknown